GleamWall
中文EN

EVGN Evogene Ltd. IFRS Annual reports only

Agricultural Chemicals · Nasdaq · SEC CIK 1574565 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY87.0%
TTM net income YoY31.0%
TTM EPS YoY44.2%
Revenue 3-yr CAGR81.7%
Net income 3-yr CAGR—

Margins

Gross margin57.3%
Operating margin-337.2%
Net margin-295.6%
FCF margin-364.5%
EBITDA margin-312.4%

Returns

ROE-311.0%
ROA-36.2%
ROIC (approx.)—
Asset turnover0.12x

Leverage & solvency

Liabilities / assets62.8%
Debt / equity—
Current ratio1.15x
Interest coverage-5.60x

Cash quality & payout

Operating cash flow / net income1.20x
Accruals ratio7.1%
Payout ratio—
Capex / revenue11.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$3.85M$5.58M
Cost of revenue$4.09M$2.38M
Gross profit-$241,000$3.20M
R&D expense$7.99M$12.51M
SG&A expense$4.29M$6.99M
Operating income-$14.03M-$18.80M
Interest expense$1.93M$3.36M
Pretax income-$13.50M-$14.81M
Income tax$1,000$9,000
Net income-$8.48M-$16.48M
EBITDA-$12.89M-$17.42M
EPS (basic)1.08-2.90
EPS (diluted)1.08-2.90
Weighted avg. shares (diluted)7.87M5.70M
Balance sheet
Cash & equivalents$12.96M$15.30M
Short-term investments—$10,000
Receivables$317,000$1.09M
Inventory$210,000$1.82M
Current assets$15.63M$21.59M
PP&E, netmay include right-of-use assets (IFRS)$812,000$1.80M
Intangibles$0$12.20M
Total assets$20.05M$39.86M
Current liabilities$3.44M$18.70M
Total liabilities$8.07M$25.03M
Shareholders' equity-$82,000-$1.45M
Shares outstanding8.72M6.51M
Cash flow statement
Operating cash flow-$13.50M-$19.70M
Capital expenditure$135,000$626,000
Free cash flow-$13.64M-$20.33M
Investing cash flow$17.74M$9.62M
Financing cash flow-$6.60M$4.66M
Depreciation & amortization$1.14M$1.38M
Stock-based compensation$654,000$1.24M

Free plan shows the latest 2 periods; Pro shows all 11 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.